|
1
|
Bateman ED: Global strategy for asthma
management and prevention 2009 (update). Report of Global
Initiative for Asthma. 2009:22009.
|
|
2
|
Girodet PO, Ozier A, Bara I, Tunon de Lara
JM, Marthan R and Berger P: Airway remodeling in asthma: new
mechanisms and potential for pharmacological intervention.
Pharmacol Ther. 130:325–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delacourt C: Bronchial changes in
untreated asthma. Arch Pediatr. 11(Suppl 2): 71s–73s. 2004.(In
French).
|
|
4
|
Black JL, Roth M, Lee J, Carlin S and
Johnson PR: Mechanisms of airway remodeling. Airway smooth muscle.
Am J Respir Crit Care Med. 164:S63–S66. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chung KF: The role of airway smooth muscle
in the pathogenesis of airway wall remodeling in chronic
obstructive pulmonary disease. Proc Am Thorac Soc. 2:347–354. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siddiqui S, Redhu NS, Ojo OO, et al:
Emerging airway smooth muscle targets to treat asthma. Pulm
Pharmacol Ther. 26:132–144. 2012. View Article : Google Scholar
|
|
7
|
Bar-Sela G, Epelbaum R and Schaffer M:
Curcumin as an anti-cancer agent: review of the gap between basic
and clinical applications. Curr Med Chem. 17:190–197. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anand P, Sundaram C, Jhurani S,
Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: an ‘old-age’
disease with an ‘age-old’ solution. Cancer Lett. 267:133–164.
2008.
|
|
9
|
Schaffer M, Schaffer PM, Zidan J and Bar
Sela G: Curcuma as a functional food in the control of cancer and
inflammation. Curr Opin Clin Nutr Metab Care. 14:588–597. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ammon HP and Wahl MA: Pharmacology of
Curcuma longa. Planta Med. 57:1–7. 1991.
|
|
11
|
Hatcher H, Planalp R, Cho J, Torti FM and
Torti SV: Curcumin: from ancient medicine to current clinical
trials. Cell Mol Life Sci. 65:1631–1652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aggarwal BB and Harikumar KB: Potential
therapeutic effects of curcumin, the anti-inflammatory agent,
against neurodegenerative, cardiovascular, pulmonary, metabolic,
autoimmune and neoplastic diseases. Int J Biochem Cell Biol.
41:40–59. 2009. View Article : Google Scholar
|
|
13
|
Yang X, Thomas DP, Zhang X, et al:
Curcumin inhibits platelet-derived growth factor-stimulated
vascular smooth muscle cell function and injury-induced neointima
formation. Arterioscler Thromb Vasc Biol. 26:85–90. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong TF, Takeda T, Li B, et al: Curcumin
disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway
inhibition. Gynecol Oncol. 122:141–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Laporte JC, Moore PE, Baraldo S, et al:
Direct effects of interleukin-13 on signaling pathways for
physiological responses in cultured human airway smooth muscle
cells. Am J Respir Crit Care Med. 164:141–148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weng SH, Tsai MS, Chiu YF, Kuo YH, Chen HJ
and Lin YW: Enhancement of mitomycin C-induced cytotoxicity by
curcumin results from down-regulation of MKK1/2-ERK1/2-mediated
thymidine phosphorylase expression. Basic Clin Pharmacol Toxicol.
110:298–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saab MB, Bec N, Martin M, et al:
Differential effect of curcumin on the nanomechanics of normal and
cancerous mammalian epithelial cells. Cell Biochem Biophys.
65:399–411. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dhandapani KM, Mahesh VB and Brann DW:
Curcumin suppresses growth and chemoresistance of human
glioblastoma cells via AP-1 and NFkappaB transcription factors. J
Neurochem. 102:522–538. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang CL, Liu YY, Ma YG, et al: Curcumin
blocks small cell lung cancer cells migration, invasion,
angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3
signalling pathway. PLoS One. 7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen JW, Tang YL, Liu H, et al:
Anti-proliferative and anti-metastatic effects of curcumin on oral
cancer cells. Hua Xi Kou Qiang Yi Xue Za Zhi. 29:83–86. 2011.(In
Chinese).
|
|
21
|
Peterson TE, Guicciardi ME, Gulati R, et
al: Caveolin-1 can regulate vascular smooth muscle cell fate by
switching platelet-derived growth factor signaling from a
proliferative to an apoptotic pathway. Arterioscler Thromb Vasc
Biol. 23:1521–1527. 2003. View Article : Google Scholar
|
|
22
|
Luo DX, Cheng J, Xiong Y, et al: Static
pressure drives proliferation of vascular smooth muscle cells via
caveolin-1/ERK1/2 pathway. Biochem Biophys Res Commun.
391:1693–1697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin L, Yang YB, Tuo QH, et al: Effects and
underlying mechanisms of curcumin on the proliferation of vascular
smooth muscle cells induced by Chol:MbetaCD. Biochem Biophys Res
Commun. 379:277–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McMillan SJ and Lloyd CM: Prolonged
allergen challenge in mice leads to persistent airway remodelling.
Clin Exp Allergy. 34:497–507. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lloyd CM, Gonzalo JA, Nguyen T, et al:
Resolution of bronchial hyperresponsiveness and pulmonary
inflammation is associated with IL-3 and tissue leukocyte
apoptosis. J Immunol. 166:2033–2040. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hamelmann E, Schwarze J, Takeda K, et al:
Noninvasive measurement of airway responsiveness in allergic mice
using barometric plethysmography. Am J Respir Crit Care Med.
156:766–775. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen G and Khalil N: TGF-beta1 increases
proliferation of airway smooth muscle cells by phosphorylation of
map kinases. Respir Res. 7:22006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang ML, Wilson JW, Stewart AG and Royce
SG: Airway remodelling in asthma: current understanding and
implications for future therapies. Pharmacol Ther. 112:474–488.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nath P, Leung SY, Williams A, et al:
Importance of p38 mitogen-activated protein kinase pathway in
allergic airway remodelling and bronchial hyperresponsiveness. Eur
J Pharmacol. 544:160–167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oh SW, Cha JY, Jung JE, et al: Curcumin
attenuates allergic airway inflammation and hyper-responsiveness in
mice through NF-κB inhibition. J Ethnopharmacol. 136:414–421.
2011.PubMed/NCBI
|
|
31
|
Moon DO, Kim MO, Lee HJ, et al: Curcumin
attenuates ovalbumin-induced airway inflammation by regulating
nitric oxide. Biochem Biophys Res Commun. 375:275–279. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Karaman M, Firinci F, Cilaker S, et al:
Anti-inflammatory effects of curcumin in a murine model of chronic
asthma. Allergol Immunopathol (Madr). 40:210–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Venkatesan N, Punithavathi D and Babu M:
Protection from acute and chronic lung diseases by curcumin. Adv
Exp Med Biol. 595:379–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sharafkhaneh A, Velamuri S, Badmaev V, Lan
C and Hanania N: The potential role of natural agents in treatment
of airway inflammation. Ther Adv Respir Dis. 1:105–120. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nel AE: T-cell activation through the
antigen receptor. Part 1: signaling components, signaling pathways,
and signal integration at the T-cell antigen receptor synapse. J
Allergy Clin Immunol. 109:758–770. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jacob A, Cooney D, Pradhan M and
Coggeshall KM: Convergence of signaling pathways on the activation
of ERK in B cells. J Biol Chem. 277:23420–23426. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gauld SB, Dal Porto JM and Cambier JC: B
cell antigen receptor signaling: roles in cell development and
disease. Science. 296:1641–1642. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nadler MJ, Matthews SA, Turner H and Kinet
JP: Signal transduction by the high-affinity immunoglobulin E
receptor Fc epsilon RI: coupling form to function. Adv Immunol.
76:325–355. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Duan W, Chan JH, Wong CH, Leung BP and
Wong WS: Anti-inflammatory effects of mitogen-activated protein
kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol.
172:7053–7059. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
De S, Zelazny ET, Souhrada JF and Souhrada
M: Role of phospholipase C and tyrosine kinase systems in growth
response of human airway smooth muscle cells. Am J Physiol.
270:L795–L802. 1996.PubMed/NCBI
|
|
41
|
Walker TR, Moore SM, Lawson MF, Panettieri
RA Jr and Chilvers ER: Platelet-derived growth factor-BB and
thrombin activate phosphoinositide 3-kinase and protein kinase B:
role in mediating airway smooth muscle proliferation. Mol
Pharmacol. 54:1007–1015. 1998.
|
|
42
|
Kumar A, Lnu S, Malya R, et al: Mechanical
stretch activates nuclear factor-kappaB, activator protein-1, and
mitogen-activated protein kinases in lung parenchyma: implications
in asthma. FASEB J. 17:1800–1811. 2003. View Article : Google Scholar
|
|
43
|
Chiou YL, Shieh JJ and Lin CY: Blocking of
Akt/NF-kappaB signaling by pentoxifylline inhibits platelet-derived
growth factor-stimulated proliferation in Brown Norway rat airway
smooth muscle cells. Pediatr Res. 60:657–662. 2006. View Article : Google Scholar
|
|
44
|
Bai J, Liu XS, Xu YJ, Zhang ZX, Xie M and
Ni W: The effect of ERK signaling pathway on cell apoptosis in
airway smooth muscle cells of chronic asthmatic rats. Xi Bao Yu Fen
Zi Mian Yi Xue Za Zhi. 26:738–741. 2010.(In Chinese).
|
|
45
|
Schlegel A, Volonte D, Engelman JA, et al:
Crowded little caves: structure and function of caveolae. Cell
Signal. 10:457–463. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shaul PW and Anderson RG: Role of
plasmalemmal caveolae in signal transduction. Am J Physiol.
275:L843–L851. 1998.PubMed/NCBI
|
|
47
|
Anderson RG: The caveolae membrane system.
Annu Rev Biochem. 67:199–225. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Okamoto T, Schlegel A, Scherer PE and
Lisanti MP: Caveolins, a family of scaffolding proteins for
organizing ‘preassembled signaling complexes’ at the plasma
membrane. J Biol Chem. 273:5419–5422. 1998.
|
|
49
|
Couet J, Belanger MM, Roussel E and Drolet
MC: Cell biology of caveolae and caveolin. Adv Drug Deliv Rev.
49:223–235. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Razani B, Woodman SE and Lisanti MP:
Caveolae: from cell biology to animal physiology. Pharmacol Rev.
54:431–467. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schubert W, Frank PG, Woodman SE, et al:
Microvascular hyperpermeability in caveolin-1 (−/−) knock-out mice.
Treatment with a specific nitric-oxide synthase inhibitor, L-NAME,
restores normal microvascular permeability in Cav-1 null mice. J
Biol Chem. 277:40091–40098. 2002.
|
|
52
|
Ramirez MI, Pollack L, Millien G, Cao YX,
Hinds A and Williams MC: The alpha-isoform of caveolin-1 is a
marker of vasculogenesis in early lung development. J Histochem
Cytochem. 50:33–42. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Thyberg J: Caveolin-1 and caveolae act as
regulators of mitogenic signaling in vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol. 23:1481–1483. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Miyawaki-Shimizu K, Predescu D, Shimizu J,
Broman M, Predescu S and Malik AB: siRNA-induced caveolin-1
knockdown in mice increases lung vascular permeability via the
junctional pathway. Am J Physiol Lung Cell Mol Physiol.
290:L405–L413. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gosens R, Stelmack GL, Dueck G, et al:
Role of caveolin-1 in p42/p44 MAP kinase activation and
proliferation of human airway smooth muscle. Am J Physiol Lung Cell
Mol Physiol. 291:L523–L534. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sun Y, Hu G, Zhang X and Minshall RD:
Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary
vascular permeability via paracellular and transcellular pathways.
Circ Res. 105:676–685, 615 p following 685. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Feng H, Guo L, Song Z, et al: Caveolin-1
protects against sepsis by modulating inflammatory response,
alleviating bacterial burden, and suppressing thymocyte apoptosis.
J Biol Chem. 285:25154–25160. 2010. View Article : Google Scholar
|
|
58
|
Buitrago C and Boland R: Caveolae and
caveolin-1 are implicated in 1α,25(OH)2-vitamin
D3-dependent modulation of Src, MAPK cascades and VDR localization
in skeletal muscle cells. J Steroid Biochem Mol Biol. 121:169–175.
2010.
|
|
59
|
Park JH, Ryu JM and Han HJ: Involvement of
caveolin-1 in fibronectin-induced mouse embryonic stem cell
proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways. J
Cell Physiol. 226:267–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Watson CS, Jeng YJ, Hu G, Wozniak A,
Bulayeva N and Guptarak J: Estrogen- and xenoestrogen-induced ERK
signaling in pituitary tumor cells involves estrogen receptor-α
interactions with G protein-αi and caveolin I. Steroids.
77:424–432. 2012.PubMed/NCBI
|
